01 Jan Israel’s P-Cure looks to expand Chinese cancer patients’ access to low-cost proton therapy after approval of new tech
Posted at 05:00h
in Asia
Israeli medical technology company P-Cure is looking to secure a strong foothold in China with its ultra-compact proton therapy system, which could help it tap into Beijing’s efforts to make advanced medical treatment affordable to mainland patients.The company, through its Chinese subsidiary SIHA, has...